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ABSTRACT
In the present work an electrospun nanofibrous membrane composed of 
polyurethane (PU), sodium bicarbonate (NaHCO3) and pantothenic acid (PA) is 
developed for treating chronic wounds. Wounds are a common health problem and 
in particular, the chronic wounds such as vascular ulcers, diabetic ulcers and pressure 
ulcers cause a large number of morbidity and mortality. The main problems of the 
chronic wounds are prolonged inflammation phase and presence of acidic environment. 
These events deactivate the operation of growth factors and also the progression of 
natural healing mechanism. So, various types of advanced textile based dressings 
are developed to address the clinical complications associated with chronic wound 
management. The prepared electrospun scaffolds were characterised to study their 
physicochemical and hemocompatible properties. The SEM micrographs depicted 
continuous, smooth-interconnected nanofibrous morphology of PU-NaHCO3-PA 
scaffolds. The FTIR spectra indicated the addition of N a H C O 3 and PA-based 
hydrophilic chemical groups which significantly enhanced the wettability of the 
composites. Further, the PU-N aH C O 3 -PA composite membrane inferred to have a 
highly porous structure with the mean porosity of 79.4% ±  4.8% which may provide 
a conducive environment for adherence and proliferation of skin cells. The composite 
scaffold also offers a highly hemocompatible surface by delaying coagulation of 
blood through contact activation pathways and by limiting red blood cells damage. 
Therefore, the excellent physicochemical properties, blood compatibility and the 
delivery of PA are anticipated to speed up the impaired healing process of chronic 
wounds.
vABSTRAK
Membran berfiber nano dengan kaedah pusingan elektro yang terdiri daripada 
polyurethane (PU), natrium bikarbonat (NaHCO 3 ) dan asid panthothenic (PA) telah 
dihasilkan bagi tujuan penyembuhan luka kronik. Membran komposit PU-NaHCO 3 - 
PA yang dihasilkan telah diperincikan berdasarkan ciri-ciri fisiokimia menggunakan 
mikroskop electron pengimbas (SEM), spektroskopi transformasi fourier inframerah 
(FTIR), analisis keliangan dan asai sudut sentuhan. Analisis keserasian darah bagi 
komposit yang dihasilkan adalah melalui masa pengaktifan thromboplastin separa 
(APTT), masa prothrombin (PT) dan asai hemolisis. Struktur berfiber nano yang 
selanjar telah diperhatikan melalui SEM bagi fiber bersaiz dalam lingkungan 152 nm ±  
63 nm. Analisis FTIR mengesahkan kehadiran bahan NaH C O 3 dan PA berdasarkan 
ciri-ciri titik tertinggi. Analisis keliangan menunjukkan bahawa membran komposit 
PU-NaHCO3-PA mempunyai keliangan yang tinggi dengan purata sebanyak 79.4% 
±  4.8% dan memberikan persekitaran yang kondusif untuk proses perkembangan sel. 
Selain itu, asai sudut sentuhan menunjukkan bahawa membran yang dihasilkan ini 
mempunyai ciri hidrofilik yang tinggi dengan purata sudut sentuhan sebanyak 74.9° ±
0.5°. Tambahan lagi, membran komposit ini juga menunjukkan keserasian yang tinggi 
dengan darah dengan melengahkan masa bagi APTT dan PT. Nisbah bagi ciri hemolisis 
dengan komposit ini kurang daripada 5%. Membran komposit PU-NaHCO 3 -PA yang 
dihasilkan mempunyai ciri fisiokimia dan keserasian darah yang lebih baik dan boleh 







TABLE OF CONTENTS vi
LIST OF TABLES viii
LIST OF FIGURES ix
LIST OF ABBREVIATIONS xii
LIST OF SYMBOLS xiii
LIST OF APPENDICES xiv
1 INTRODUCTION 1
1.1 Overview 1
1.2 Research background 2
1.3 Problem statement 4
1.4 Research objectives 5
1.5 Scope of the work 6
1.6 Significance of the study 6
2 LITERATURE REVIEW 7
2.1 Chronic wounds 7
2.2 Healing of chronic wounds 8
2.3 Electrospinning 9
2.3.1 Technique 9
2.3.2 Loading drugs or biomolecules into
electrospun nanofibers 10
2.3.3 Essential parameters in the electrospin­
ning process 11
TABLE OF CONTENTS
2.4 Components in the proposed nanofibrous mem­
brane 13
2.4.1 Polyurethane 13
2.4.2 Sodium bicarbonate 15
2.4.3 Pantothenic Acid 17
3 MATERIALS AND METHODS 18
3.1 Preparation of the membranes 18
3.1.1 Fabrication of the PU control membrane 18
3.1.2 Fabrication of the novel PU-NaHCO3-
PA composite membrane 19
3.2 Physico-chemical characterization 22
3.2.1 Scanning Electron Microscopy 22
3.2.2 Fourier Transform Infrared Spectroscopy 23
3.2.3 Porosity measurement 24
3.2.4 Contact angle assay 25
3.3 Hemocompatibility studies 26
3.3.1 Activated partial thromboplastin time 26
3.3.2 Prothrombin time 27
3.3.3 Hemolysis assay 27
4 RESULTS AND DISCUSSION 29
4.1 Preparation of the membranes 29
4.2 Physico-chemical characterization 32
4.2.1 Scanning Electron Microscopy 32
4.2.2 Fourier Transform Infrared Spectroscopy 35
4.2.3 Porosity measurement 40
4.2.4 Contact angle assay 42
4.3 Hemocompatibility studies 46
4.3.1 Activated partial thromboplastin time 46
4.3.2 Prothrombin time 49




Appendices A -  H
56






Preparation of PU-NaHCO3-PA composite solutions testing 
settings a-f by the use of different solvents, concentrations 
and ratios; Fabrication of novel PU-NaHCO3-PA composite 
membranes using the solutions d-f and suitable electrospin­
ning paramters such as voltage, flow rate and collector 
distance
Results of the prepared PU-NaHCO3-PA composite solu­
tions testing settings a-f by the use of different solvents, 
concentrations and ratios; Results of the fabricated PU- 
N aH C O 3-PA composite membranes using the solutions d-f 
and suitable electrospinning paramters such as voltage, flow 








2.2 Types of electrospinning
2.3 Essential parameters in the electrospinning process
2.4 Chemical structure of polyurethane
2.5 Chemical structure of sodium bicarboante
2.6 Chemical structure of pantothenic acid
3.1 Electrospinning set-up which includes mechanical pump, 
power supply and grounded collector
3.2 Polaron Division SEM coating system
3.3 Measurement set-up of Scanning Electron Microscopy
3.4 Measurement set-up of Fourier Transform Infrared Spec­
troscopy
3.5 VCA Optima contact angle measurement unit
3.6 Measurement set-up for hemolysis assay, Spectrophotometer 
GENESYS 10S UV-VIS (Thermo Scientific, Malaysia)
4.1 Fiber size of the PU control and composite membranes PU- 
NaHCO3-PA(3) and PU-NaHCO3-PA(4)
4.2 Scanning Electron Microscopy (SEM) image of the 
polyurethane control membrane (7000x)
4.3 SEM images of the composite membranes A) PU-NaHCO3- 
PA(1), B) PU-NaHCO3-PA(2), C) PU-NaHCO3-PA(3), D) 
PU-NaHCO3-PA(4) at magnification 7000x
4.4 Fourier Transform Infrared Spectrum of the ingredients 
sodium bicarbonate (N aH CO 3 ), pantothenic acid (PA), 
the polyurethane (PU) based control membrane and the 
composite membranes PU-NaHCO3-PA(3,4) between the 


















x4.5 Fourier Transform Infrared Spectrum of the ingredients 
sodium bicarbonate (N aH CO 3), pantothenic acid (PA), 
the polyurethane (PU) based control membrane and the 
composite membranes PU-NaHCO3-PA(3,4) between the 
wavenumber k = 1500 cm-1 - 2000 cm-1
4.6 Fourier Transform Infrared Spectrum of the ingredients 
sodium bicarbonate (N aH CO 3 ), pantothenic acid (PA), 
the polyurethane (PU) based control membrane and the 
composite membranes PU-NaHCO3-PA(3,4) between the 
wavenumber k = 2000 cm-1 - 2500 cm-1
4.7 Fourier Transform Infrared Spectrum of the ingredients 
sodium bicarbonate (N aH CO 3 ), pantothenic acid (PA), 
the polyurethane (PU) based control membrane and the 
composite membranes PU-NaHCO3-PA(3,4) between the 
wavenumber k = 3000 cm-1 - 4000 cm-1
4.8 Measurement data of porosity of the PU control and the PU- 
NaHCO3-PA(3) and PU-NaHCO3-PA(4)
4.9 Result graphics of porosity of the PU control and the PU- 
NaHCO3-PA(3) and PU-NaHCO3-PA(4)
4.10 Contact angle images of the A) PU control and the composite 
membranes B) PU-NaHCO3-PA(3) and C) PU-NaHCO 3 - 
PA(4)
4.11 Measurement data of contact angle of the PU control and 
the composite membranes PU-NaHCO3-PA(3) and PU- 
NaHCO3-PA(4)
4.12 Result graphics of contact angles of the PU control 
and composite membranes PU-NaHCO3-PA(3) and PU- 
NaHCO3-PA(4)
4.13 Measurement data of Activated partial thromboplastin time 
(APTT) assay of the PU control and both composite 
membranes PU-NaHCO3-PA(3) and PU-NaHCO3-PA(4)
4.14 Result graphics of Activated partial thromboplastin time 
(APTT) of the PU control and both composite membranes 
PU-NaHCO 3 -PA(3) and PU-NaHCO3-PA(4)
4.15 Measurement data of Prothrombin time (PT) assay of the PU 

















Result graphics of Prothrombin time (PT) of the PU control 
and both composite membranes PU-NaHCO3-PA(3) and 
PU-NaHCO3-PA(4) 51
Measurement data of Hemolysis assay of the PU control 
and the composite membranes PU-NaHCO3-PA(3) and PU- 
NaHCO3-PA(4) 53
Result graphics of hemolysis ratio (HR) (%) of the PU control 




APTT - Activated partial thromboplastin time
CA - Cellulose acetate
CDC - Center for Disease Control
FTIR - Fourier transform infrared spectroscopy
GO - graphene oxide
NO - Nitric oxide
PA - Pantothenic acid
PBS - Phosphate buffered solution
PLA - polylactic acid
PLLA - Poly-L-lactide
PT - Prothrombin time
PU - Polyurethane
PPP - Platelet poor plasma
RBC - Red blood cells
RVP - Retrograde venous perfusion
SEM - Scanning electron microscopy
SD - Standard deviation
WP - Work package




























Weight of the solute
Weight of the wet sample
Weight of the dry sample
Sodium bicarbonate
Absorbance of the negative control
Hemolysis ratio
Level of significance
Absorbance of the positive control
Specific gravity
Absorbance of the test sample
Voltage
Volume
Volume of solution 
Flow rate






A Scanning electron microscopy 62
B Porosity measurement 66
C Contact angle assay 67
D Activated partial prothromboplastin time 68
E Prothrombin time 69
F Hemolysis assay 70
G Polyurethane data sheets 71




A wound could be described as an injury on the skin surface by physical, 
chemical, mechanical or thermal damages. There are two types of wounds in case of 
wound healing: acute and chronic wounds. Acute wounds are caused by traumas and 
usually curable within 8 to 12 weeks. These wounds are often caused by mechanical 
damage, but can be also formed by exposure to extreme heat, irradiation, electrical 
shock or corrosive chemicals [1]. In addition, acute wounds pass well organized 
through all repair mechanism like coagulation, inflammation, formation of granulation 
tissue, and remodelling. In contrast, chronic wounds do not pass all phases of wound 
healing. They often stay in the inflammatory phase and are commonly originated due 
to specific diseases like diabetes or tumors [2]. Moreover, the healing takes more than 
12 weeks and the recurrence of the wounds is possible [1]. Another classification of 
wounds is according to their appearance. There are moist and dry wounds [3]. The 
wound healing of these different types is affected by many parameters. One important 
factor is the pH value. Variations in pH may affect e.g. wound closure, microbial 
infection rates, bacterial virulence and biofilm formation [4]. Several researches show 
that wound healing occurs more effectively at low pH [5]. In case of moist chronic 
wounds studies show different results. Some research groups report that an alkaline 
environment is more advantageous and some refer that an acid environment is more 
beneficial for chronic wound healing. But it is proven that the pH value influences the 
wound healing [4]. Thus, the pH is one important parameter which can be recognized 
in wound treatment. In addition, the treatment of a wound varies depending on the 
type of the wound. Due to the difficulties in treatment of chronic wounds, traditional 
dressings which include cotton, wool, natural or synthetic bandages and gauzes are 
largely replaced by novel advanced dressings. Modern materials which are currently 
utilized for wound healing are natural inert polymers, natural bioactive materials, 
synthetic polymers and hydrogels [3]. Electrospinning is a widely used technique to
2manufacture nanofibers from different natural or synthetic polymers, metal, ceramic 
or glass material. Thus, it has a broad range of applications such as filtration, textiles, 
energy, acoustics, as well as medicine [6].
1.2 Research background
In the past, traditional dressings such as bandages, cotton wool, lint and gauzes 
were used for the management of wounds. These dressings kept the wound dry by 
absorbing the wound exudate and prevented the entry of bacteria into the wound. 
But it has been shown in several studies that a warm and moist wound environment 
is more beneficial for successful wound healing [7]. Thus, advanced dressings are 
developed. They have biological activity on its own or release bioactive ingredients. 
In contrast, solutions, creams, and ointments which include bioactive molecules are 
not very effective for drug delivery to the wounds. Similarly, traditional dressings 
like gauze and cotton wool take no active part in the wound healing process. In 
advanced dressings, cleansing and debriding agents can remove necrotic tissue and 
have an antimicrobial effect which prevents or treats infection and proliferates growth 
factors to aid tissue regeneration. In addition, advanced dressings provide a moist 
environment [3]. Chronic wounds require a specific control of bacterial load and 
moisture level. These facts show that advanced dressings are suitable for the treatment 
of chronic wounds [8]. There are different types of advanced wound dressings which 
can be classified in a number of ways depending on e.g. the function in the wound 
(debridement, antibacterial, occlusive, absorbent, adherence), the type of material 
employed to produce the dressing (hydrocolloid, alginate, collagen) or the physical 
form of the dressing (ointment, film, foam, gel). Furthermore, dressings can be 
ranged into primary, secondary and island dressings. Primary dressings have physical 
contact with the wound, secondary dressings cover the primary dressing and island 
dressings have a central absorbent region which is surrounded by an adhesive portion. 
Classification criteria can be useful to select a dressing for specific wound treatment
[7]. For instance, bioadhesive polymeric (synthetic, semisynthetic, or naturally 
derived) dressings are potentially useful in the treatment of local infection. They can 
achieve increased local concentrations of antibiotics and avoid high-systemic dose to 
reduce the patient exposure. Composite dressings which are made of synthetic and 
natural polymers are also known for controlled drug delivery. The degree of swelling, 
cross-linking density and degradation rate can be controlled, so that delivery kinetics 
are adapted according to the desired drug release. Basically, the drug release from 
polymeric formulations is influenced by some physical processes like hydration of the
3polymer by fluids, swelling to form a gel, diffusion of drug through the polymer matrix 
and eventual erosion of the polymeric system. The contact of a dry polymeric dressing 
with a moist wound surface effects the permeation of the wound moisture into the 
polymer matrix [3].
Polymeric materials were used in the composition of wound dressings. 
They can be divided into natural inert, natural bioactive and synthetic polymers. 
Synthetic polymers commonly used in wound dressings include polyvinylalcohol, 
polyethylene oxide and PU [3]. Their hydrophilic nature procures important functional 
wound healing characteristics e.g. moisture absorption capacity and water vapour 
transmission [8] [3]. In addition, they are generally adhesive, biocompatible and 
has excellent mechanical strength which allows them to stay longer than the natural 
polymers. Hence, the natural or bioactive polymers are widely used in combination 
with synthetic materials which ultimately yields a better wound healing product [3]. 
In tissue engineering, many reports expose the fabrication of electrospun nanofibers 
by using biocompatible polymers for skin, vasculature, heart and cornea as well as 
bone substitutes and nerve regeneration [9], [3]. The suitable properties of electrospun 
nanofibers for biomedical applications consist in their highly porous structure which 
is similar to the structure of extracellular matrix, high levels of gas permeation and 
surface-to-volume ratio [10], [3]. These properties accelerate a lot of healing processes 
such as cell respiration, skin regeneration, moisture retention, removal of exudate and 
hemostasis [10]. Especially, the presence of a high porosity with small pores enables a 
good permeability for oxygen and water, a good adsorption of liquid and protects the 
wound from bacterial penetration and dehydration. In addition, the high surface area 
of the nanofibers support the migration of keratinocytes on the wound surface and can 
improve the healing process. Moreover, nanofibrous materials offer a local delivery of 
therapeutic agents, such as antibiotics or growth factors [3].
Modern materials for chronic wound therapy include hydrocolloids, alginates 
and hydrogels. These ingredients afford a moist environment stimulating wound 
healing. There are several new techniques for the healing of infected ulcers. 
For these methods triphala incorporated collagen is used. Another possibility of 
treatment is the application of an electric field to a flowing medium which forms 
microscale and nanoscale structures to compose functional wound healing materials. 
In more advanced applications, commercial tissue engineered skin agents based on 
acelluar (AllodermTM) or cell containing membranes (Dermagraft TM, ApligraftTM, 
EpicelTM, TransCyteTM, etc.) are developed. But this type of treatment is expensive 
and limited available. The application of biopolymer nanofibers provides a cheap and
4effective alternative for wound treatment and can be used more easily standardized 
[6]. There are already different PU composite membranes for wound healing in 
research e.g. PU-propolis, PU-olive oil/copper oxide nanocrystals, and PU-nitric oxide 
[11, 12, 13]. But there is a research gap regarding particular dressings for chronic 
wounds. In this project, a novel electrospun nanofibrous composite membrane which is 
especially suited to chronic wound healing is developed. The novel membrane includes 
the agents pantothenic acid (PA) and sodium bicarbonate (N aH CO 3) which have cell 
proliferating and antibacterial effects and are already used in chronic wound treatment 
[14, 15, 16].
1.3 Problem statement
Chronic wounds are a global healthcare problem. For instance, in 2011 the 
Center for Disease Control (CDC) assessed that 25.8 million people in the US are 
affected by diabetes mellitus. Fifteen percent of them developed lower extremity ulcers 
and up to 25% of foot ulcer patients will eventually undergo amputation [10]. Each 
year about 1.7 million new cases of diabetes in adults are determined. Thus, it is 
expected that in 2050 one out of every three adults in the United States will have 
diabetes [17]. For this reason it can be inferred that the amount of people affected by 
chronic wounds will also increase.
Previous literature reviews have shown that the treatment of chronic wounds is 
very time-consuming in medical care. The wound healing needs about several months 
or years or never occurs so that amputation could be necessary. In all cases, the therapy 
of chronic wounds is expensive. Although standard materials like gauzes and bandages 
are cheap to manufacture, they have to be changed frequently [18]. Moreover, standard 
materials could be only used if wound healing does not need longer than four weeks. 
Otherwise, alternative methods would be needed [19]. For instance, oxygen-associated 
therapies offer an alternative solution to improve wound healing. In this therapy, a bag 
with pure oxygen which encases the wound is used. Due to the immobility during 
the treatment the oxygen-associated method is very time-consuming and inconvenient 
for the patient. The negative pressure therapy provides a further treatment option. It 
uses PU foam combined with a vacuum pump to reduce the wound area, to provide 
a moist wound environment and to support blood circulation. This method is only 
usable in small wounds. Another disadvantage is arised out of the immobility and 
potential pain during the regular therapy performed by medical staff. Stem cell 
application provides a further solution to treat wounds. It uses a natural material
5which does not result in any side effect but it involves an invasive and very painful 
procedure [3]. Due to the mentioned disadvantages a novel nanofibrous membrane 
suited to the nature of chronic wounds was developed in this study. The production 
of nanofibers could be done using various processing techniques like drawing out, 
molecular self-assembly, thermally induced phase separation or electrospinning. But 
by manufacturing continuous polymeric nanofibers electrospinning is the only method 
which is able to manipulate and control the surface area, fiber diameter, porosity and 
base weight of the membrane [6].
In the present project, a novel nanofibrous composite membrane was developed 
using electrospinning technique. This model was suited to chronic wounds by the 
use of the antibacterial material N aH C O 3 and the cell-proliferating material PA. The 
antibacterial part may help the wound to merge from the inflammatory phase into the 
following proliferation phase. The cell-proliferating part of the novel product may 
support the proliferation phase, so that it may offer promising properties to improve 
the wound healing mechanism and the patient’s compliance, shorten the medical care 
and reduce treatment costs. Therefore, the following problem statements reveal:
1. There is a continuous research to improve nanofibrous composite membranes 
for wound healing.
2. While developing a novel membrane for wound healing the physico-chemical 
properties have to be examined.
3. Blood compatibility is one of the important qualities which has to be evaluated 
for a wound healing membrane.
1.4 Research objectives
Main objectives are:
1. To fabricate and optimize a composite membrane (PU-NaHCO3-PA) for 
wound treatment.
2. To characterize the physico-chemical changes of the composite membrane.
3. To analyse the hemocompatible nature of the composite membrane in order to 
assess its efficacy.
61.5 Scope of the work
Chronic wound healing is a major health issue faced by millions of people. 
The problem of slow healing makes it difficult for patients to recover completely 
and it also involves a continuous medical surveillance [18]. Hence, to reduce the 
economic burden on chronic wounds and improve the patient compliance a cost 
effective nanofibrous composite membrane is proposed in this research. Initially, the 
PU beads will be dissolved using dimethylformamide (DMF) solvent by adapting 
appropriate concentration. Then, the N aH C O 3 and PA composite solution will be 
prepared using suitable solvents. After preparing the PU and PU composite mixtures, 
the electrospinning process will be carried out using optimized flow rate, voltage and 
collector distance. Further to display the physico-chemical properties of prepared 
membranes, characterization tests like scanning electron microscopy (SEM) analysis, 
Fourier transform infrared spectroscopy (FTIR), porosity measurement and contact 
angle assay will be carried out. Finally, the hemocompatibility improvement of the 
composite membrane will be explored through in vitro assays of activated partial 
thromboplastin time (APTT), prothrombin time (PT) and hemolysis.
1.6 Significance of the study
The number of people affected by chronic wounds grows rapidly due to the 
increasing age of population [20][3]. Thus, the risk of delayed wound healing increases 
and the possibility of necessary amputations and in severe cases mortality rises [3]. 
Reports in the United States estimate that $25 billion are spent annually on the 
treatment of chronic wounds. The morbidity and costs of wound care create a need 
for cost-effective wound healing products [20]. A novel membrane suited to chronic 
wounds may improve the success rate of chronic wound healing and thus reduce 
hospital stays, nursing time and costs.
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